Skip to main content

Table 3 Maternal values of neonatal outcomes favoring different therapeutic indomethacin options

From: A prospective study of maternal preference for indomethacin prophylaxis versus symptomatic treatment of a patent ductus arteriosus in preterm infants

Outcome Women favored prophylactic approach Mean (SD) Women favored symptomatic approach Mean (SD) Mean difference (95% CI) p- value
PDA 41 (21) 44 (24) −3 (−9, 3) 0.3
IVH 28 (23) 35 (25) −7 (−14, −0,3) 0.04
BPD 35 (22) 40 (23) −5 (−12, 1) 0.11
PDA ligation 38 (24) 39 (30) −1 (−9, 6) 0.7
Oliguria 63 (22) 55 (21) 8 (2, 15) 0.01
Neurosensory outcome 65 (27) 58 (24) 7 (−1,14) 0.09
  1. BPD, bronchopulmonary dysplasia; IVH, intraventricular hemorrhage; PDA, patent ductus arteriosus.